Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models.
about
Positional variations in mammary gland development and cancerRapamycin delays growth of Wnt-1 tumors in spite of suppression of host immunity.Adiponectin haploinsufficiency promotes mammary tumor development in MMTV-PyVT mice by modulation of phosphatase and tensin homolog activitiesMolecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer.Guidelines for the welfare and use of animals in cancer research.Novel role of Engrailed 1 as a prosurvival transcription factor in basal-like breast cancer and engineering of interference peptides block its oncogenic function.The tumour suppressor C/EBPδ inhibits FBXW7 expression and promotes mammary tumour metastasis.Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer.P53 genotype as a determinant of ER expression and tamoxifen response in the MMTV-Wnt-1 model of mammary carcinogenesisMonitoring therapeutic efficacy of sunitinib using [(18)F]FDG and [(18)F]FMISO PET in an immunocompetent model of luminal B (HER2-positive)-type mammary carcinomaImaging Tumor Necrosis with FerumoxytolNon-germline genetically engineered mouse models for translational cancer research.Genomic analyses as a guide to target identification and preclinical testing of mouse models of breast cancerHypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancerMolecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1.Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics.Alk5 inhibition increases delivery of macromolecular and protein-bound contrast agents to tumors.Unlocking the power of cross-species genomic analyses: identification of evolutionarily conserved breast cancer networks and validation of preclinical modelsHaploinsufficiency in the prometastasis Kiss1 receptor Gpr54 delays breast tumor initiation, progression, and lung metastasisLoss of TGF-beta or Wnt5a results in an increase in Wnt/beta-catenin activity and redirects mammary tumour phenotype.Cholesterol-induced mammary tumorigenesis is enhanced by adiponectin deficiency: role of LDL receptor upregulation.Development of novel tumor-targeted theranostic nanoparticles activated by membrane-type matrix metalloproteinases for combined cancer magnetic resonance imaging and therapyThe enhancing effects of obesity on mammary tumor growth and Akt/mTOR pathway activation persist after weight loss and are reversed by RAD001.
P2860
Q27008355-8827E62A-8A69-4218-B779-2FFD263471F6Q33345588-A38CC73C-451A-4E5C-A289-D0957CAEACD9Q33421722-AA5241D9-087E-4C8F-9E77-D034FEE74380Q33566627-C492CD58-A2CD-4884-9C3C-0E65CEE90F1BQ33903753-9DD16943-11E3-4B88-B386-64A60646A3F9Q34285190-A7298CA5-CF78-40BF-A0EC-3BDDA6DA7362Q34479984-4DAD908B-F378-4453-967E-74006DB753D2Q35144029-D293E00E-01B7-44E4-B87D-96EE67E3A675Q35455993-1E44D7D5-C1CC-4C07-8D59-3E699087E179Q35703904-B6095E2E-4B75-45DD-9D07-FEBF14092A64Q35841636-E9D6A7D6-31D4-4F6B-B1FC-B2D098A0AE7CQ36150711-1E04977D-22D3-45C8-92CE-5F6676F741DCQ36353160-CEC1FDDC-C9EB-497F-A302-4E9A9254A887Q36393103-BC3F3E06-966A-4DDF-A52A-CD9CB3519E95Q36579305-24DE1AC1-721E-4991-BFC4-13AB2B42F402Q36643063-30B64899-1FB9-4CBA-92A6-804EEABCF73EQ36892526-C8716314-976C-4B58-9AF2-57451D2141C3Q37038608-7F16A3E5-0431-4F03-8C3E-8C3FB6F90B4FQ37105376-7810762A-C2C5-4D8A-9840-74728CEDAC53Q37208778-8FFD82FC-B59E-4253-BF90-47630BA0BC41Q37381628-4F9A6ABA-83EE-4716-923C-BC3A29318A2FQ37624281-56911612-8E4F-40A0-BD2B-D06C6548C56AQ39403993-6AAA3736-9EC6-4755-A033-59917216EBBD
P2860
Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Accelerated preclinical testin ...... ed mouse breast cancer models.
@en
Accelerated preclinical testin ...... ed mouse breast cancer models.
@nl
type
label
Accelerated preclinical testin ...... ed mouse breast cancer models.
@en
Accelerated preclinical testin ...... ed mouse breast cancer models.
@nl
prefLabel
Accelerated preclinical testin ...... ed mouse breast cancer models.
@en
Accelerated preclinical testin ...... ed mouse breast cancer models.
@nl
P2093
P1476
Accelerated preclinical testin ...... red mouse breast cancer models
@en
P2093
Ana I Robles
Carrie A Bonomi
Chuxia X Deng
David J Munroe
Glenn Merlino
Howard Stotler
J Carl Barrett
James Cherry
Jeff E Green
John P Carter
P304
P356
10.1158/1078-0432.CCR-06-0918
P407
P577
2007-04-01T00:00:00Z